MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ZILVERSMIT, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ZILVERSMIT, R.

Molecular Pharmacology, Vol 7, 674-682, Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics

Thioxanthones

II. Studies on the Hydrogen-Bonding Capacity of Lucanthone

ROLF ZILVERSMIT 1

1 Hematology Service, Mount Sinai Hospital Services, Elmhurst, New York 11373, and Department of Medicine, The Mount Sinai School of Medicine of The City University of New York, New York, New York 10029

Lucanthone (1-diethylaminoethylamino-4-methylthioxanthone) is a bacteriostatic and carcinostatic agent, and combines readily with DNA. N11-Methyl substitution results in virtual deletion of these activities. It has been postulated that this effect is due to loss of the capacity to form in an intermolecular hydrogen bond.

Suitable investigations of electronic and vibrational spectra indicate the presence of a stable intramolecular amino-carbonyl proton bond in lucanthone. The studies reveal no evidence of interaction between strong hydrogen-bonding acids or bases and the carbonyl or secondary amine substituents.

Consequently, the reduced biological and biochemical activity concomitant with N-methyl substitution is not attributable to a diminished capacity to form intermolecular proton bonds. In fact, the capability of lucanthone in this regard is lower than that of the less active N-methyl derivative, in which the nonbonding 2p orbital of the carbonyl function is free to interact with hydrogen-bonding acids.

Note:
ACKNOWLEDGMENTS I thank Dr. I. B. Weinstein and Dr. E. Hirschberg for supplying lucanthone and its N-methyl derivative, and Mrs. E. Felten for preparing the illustrations.

Submitted on April 7, 1971







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics